The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJTOW.L Regulatory News (JTOW)

  • There is currently no data for JTOW

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Closing Notice Announcement

24 Sep 2019 07:00

RNS Number : 3834N
J2 Acquisition Limited
24 September 2019
 

For immediate release

J2 ACQUISITION LIMITED

 

(the "Company")

24 September 2019

ANTICIPATED 1 OCTOBER 2019 COMPLETION DATE OF ACQUISITION OF APi GROUP, INC.

AND

WARRANT FINANCING CONSENT SOLICITATION UPDATE

The Company announced on 3 September 2019 that it had entered into an agreement to acquire APi Group, Inc., for approximately $2.9 billion (the "Transaction"). The Company today announces that the completion of the Transaction is presently anticipated to occur on 1 October 2019, or as promptly as practicable thereafter upon the satisfaction of any remaining closing conditions.

 

In addition, the Company announced on 3 September 2019 that it despatched a warrant consent solicitation memorandum to holders of its warrants seeking from those warrantholders, a commitment to exercise their warrants at a reduced exercise price of US$10.25 (the "Warrant Financing") and their consent to shorten, conditional upon the consummation of the Transaction, the subscription period of the warrants to expire upon the consummation of the Transaction (subject to certain limited exceptions) (the "Warrant Consent Solicitation").

 

The Company today announces that it has closed the Warrant Consent Solicitation. All warrantholders who committed to participate in the Warrant Financing are requested to immediately instruct their broker/nominee to cause the exercise of all Company warrants beneficially owned by them and/or their affiliates on or before 26 September 2019. The final date for receipt by the Company's agent, Computershare, of subscription funds from warrantholders who are exercising their warrants is 9:00 am New York time / 2:00 pm London time on 26 September 2019. The ordinary shares issued upon exercise of the warrants are expected to be allotted immediately prior to the consummation of the Transaction. All unexercised warrants will remain outstanding following the closing of the Transaction on their original terms.

 

Warrantholders and their agents may contact the Company's agent, Computershare, on +44 (0) 370 702 0000 with any questions regarding their warrant exercise and remittance of subscription funds.

Further updates regarding completion of the Transaction will be made as appropriate.

--Ends--

Distribution Restrictions

The distribution of this announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes are required to inform themselves about, and to observe, any such restrictions. This announcement does not constitute or contemplate an invitation to participate in the warranting financing and/or the consent solicitation in any jurisdiction in which, or to any person to whom, it is unlawful to make such invitation or for there to be such participation under applicable securities laws.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQGXGDCDSDBGCS
Date   Source Headline
29th May 20203:55 pmRNSAPi Announces Cancellation of Listing from LSE
30th Apr 20207:00 amRNSTR-1 - Notification of major holdings
30th Apr 20207:00 amRNSTR-1 - Notification of major holdings
29th Apr 202012:00 pmRNSAPi Announces Commencement of Trading on NYSE
27th Apr 20207:00 amRNSAPi Announces Anticipated Listing Date on NYSE
9th Apr 20207:00 amRNSAPi Group Reports 4Q and FY 2019 Financial Results
24th Dec 201912:30 pmRNSAPi Group Announces Confidential Submission of S-4
20th Nov 20192:15 pmRNSAPi Group Announces DTC Settlement Eligibility
20th Nov 201912:30 pmRNSAPi Reports Third Quarter and Nine Month Results
16th Oct 20197:00 amRNSAPi Announces Anticipated Settlement Eligibility
9th Oct 20197:00 amRNSChange of ISINs and SEDOLs
4th Oct 201911:30 amRNSTR-1 - Notification of major holdings
3rd Oct 20192:00 pmRNSTR-1 - Notification of major holdings
3rd Oct 20192:00 pmRNSTR-1 - Notification of major holdings
3rd Oct 20192:00 pmRNSAPi Group Corporation - PDMR Notification
2nd Oct 20197:00 amRNSTotal Voting Rights and Share Capital Information
1st Oct 20194:57 pmRNSJ2 Acquisition Completes Acquisition of APi Group
1st Oct 20197:00 amRNSSecured Debt Credit Facilities Successful Results
24th Sep 20197:00 amRNSClosing Notice Announcement
17th Sep 20194:26 pmRNSWarrant Financing Consent Solicitation Update
3rd Sep 201911:25 amRNSLaunch of Warrant Financing / Consent Solicitation
3rd Sep 20197:00 amRNSJ2 Acquisition Limited to Acquire APi Group, Inc.
16th Aug 201912:07 pmRNSSecond Price Monitoring Extn
16th Aug 201912:02 pmRNSPrice Monitoring Extension
14th May 20194:30 pmRNSHalf-year Report
28th Feb 20194:42 pmRNSSecond Price Monitoring Extn
28th Feb 20194:36 pmRNSPrice Monitoring Extension
2nd Jan 20194:46 pmRNSSecond Price Monitoring Extn
2nd Jan 20194:36 pmRNSPrice Monitoring Extension
13th Nov 20181:50 pmRNSAnnual Financial Report
16th May 20182:30 pmRNSHalf-year Report
9th Feb 20184:41 pmRNSSecond Price Monitoring Extn
9th Feb 20184:36 pmRNSPrice Monitoring Extension
28th Dec 20174:40 pmRNSSecond Price Monitoring Extn
28th Dec 20174:35 pmRNSPrice Monitoring Extension
16th Oct 20173:31 pmRNSNotification of major holding TR1
12th Oct 20171:15 pmRNSHolding(s) in Company
10th Oct 20177:00 amRNSAdmission to Trading on the London Stock Exchange
5th Oct 20174:02 pmRNSPublication of a Prospectus
5th Oct 20177:00 amRNSResults of IPO of J2 Acquisition Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.